Combination Therapy For Ad From Data

Invention Novelty

Value Proposition

Technology Description

This groundbreaking technology leverages advanced computational techniques to predict combination therapies for Alzheimer’s disease (AD) by integrating multi-domain datasets, including single-cell human transcriptomics, drug perturbation data, and clinical records. 

Currently in the pre-clinical stage, this invention represents a novel, data-driven method for precision medicine in neurodegenerative diseases. By addressing the multifactorial nature of AD through cell-specific therapeutic strategies, this technology offers a promising new avenue for developing more effective treatments for AD and potentially other complex diseases.

Application

Looking for Partners

Stage of Development

Related Materials

Data Availability

Patent Status

Patent Pending